Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Holmes

Showing results (391-400 of 451) with videos related to

Pageof 46
Sort By:
Frontiers in Immunology|September 23, 2022
Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccinationHope R Lapointe, Francis Mwimanzi, Peter K Cheung, et al.
Gut|February 26, 2009
Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signallingG Trynka, A Zhernakova, J Romanos, et al.
The Hospital|May 30, 2018
St. Bartholomew's HospitalSamuel Gee, Dyce Duckworth, T Lauder Brunton, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Older Adults Mount Less Durable Humoral Responses to a Two-dose COVID-19 mRNA Vaccine Regimen, but Strong Initial Responses to a Third DoseFrancis Mwimanzi, Hope R Lapointe, Peter K Cheung, et al.
Physical Review Letters|June 28, 2011
Gravity Probe B: final results of a space experiment to test general relativityC W F Everitt, D B DeBra, B W Parkinson, et al.
The Journal of Infectious Diseases|May 11, 2022
Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third DoseFrancis Mwimanzi, Hope R Lapointe, Peter K Cheung, et al.
Nature Genetics|June 15, 2007
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21David A van Heel, Lude Franke, Karen A Hunt, et al.
The Journal of Infectious Diseases|June 7, 2022
People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose ResponsesHope R Lapointe, Francis Mwimanzi, Peter K Cheung, et al.
Nature Genetics|March 4, 2008
Newly identified genetic risk variants for celiac disease related to the immune responseKaren A Hunt, Alexandra Zhernakova, Graham Turner, et al.
The European Physical Journal. C, Particles and Fields|May 9, 2025
Reweighting simulated events using machine-learning techniques in the CMS experimentA Hayrapetyan, A Tumasyan, W Adam, et al.
Pageof 46

Showing results (391-400 of 451) with videos related to

Sort By:
Pageof 46
Frontiers in Immunology|September 23, 2022
Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccinationHope R Lapointe, Francis Mwimanzi, Peter K Cheung, et al.
Gut|February 26, 2009
Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signallingG Trynka, A Zhernakova, J Romanos, et al.
The Hospital|May 30, 2018
St. Bartholomew's HospitalSamuel Gee, Dyce Duckworth, T Lauder Brunton, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Older Adults Mount Less Durable Humoral Responses to a Two-dose COVID-19 mRNA Vaccine Regimen, but Strong Initial Responses to a Third DoseFrancis Mwimanzi, Hope R Lapointe, Peter K Cheung, et al.
Physical Review Letters|June 28, 2011
Gravity Probe B: final results of a space experiment to test general relativityC W F Everitt, D B DeBra, B W Parkinson, et al.
The Journal of Infectious Diseases|May 11, 2022
Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third DoseFrancis Mwimanzi, Hope R Lapointe, Peter K Cheung, et al.
Nature Genetics|June 15, 2007
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21David A van Heel, Lude Franke, Karen A Hunt, et al.
The Journal of Infectious Diseases|June 7, 2022
People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose ResponsesHope R Lapointe, Francis Mwimanzi, Peter K Cheung, et al.
Nature Genetics|March 4, 2008
Newly identified genetic risk variants for celiac disease related to the immune responseKaren A Hunt, Alexandra Zhernakova, Graham Turner, et al.
The European Physical Journal. C, Particles and Fields|May 9, 2025
Reweighting simulated events using machine-learning techniques in the CMS experimentA Hayrapetyan, A Tumasyan, W Adam, et al.
Pageof 46